StockTipsArenaBeta

BUY Aurobindo Pharma — Chandan Taparia, Motilal Oswal

BUYAurobindo Pharma
Aurobindo Pharma share price target & all analyst calls

byChandan Taparia, Motilal OswalHorizon: NA (inferred Swing (≤2wk))1 Sept 2026via LiveMint Buy-or-Sell (topic)

Entry₹1,700Inferred
Target₹1,820
Total upside +7.06% (call closed)
Stop lossNot given
At expiry₹1,66015 Sept 2026, 3:30 pm
Expired-2.35%auction close
Follow Chandan Taparia for new calls(30% target hit, 259 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 1 active Swing call on AUROPHARMASee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 15 Sept 2026
12 supporting4 neutral3 opposing
Supports the BUY call (12)

Aurobindo Pharma gets US FDA nod to sell first metered-dose asthma inhaler in US

NewsCnbc-Tv18·15 Sept · today

(opens in new tab)

Aurobindo Pharma received final US FDA approval for its Beclomethasone Dipropionate HFA Inhalation Aerosol in 40 mcg and 80 mcg strengths.

BSE · Company Update·15 Sept · today

(opens in new tab)

Aurobindo Pharma has received final approval from the USFDA for its Beclomethasone Dipropionate HFA Inhalation Aerosol in 40 mcg and 80 mcg strengths.

NSE · Press Release·15 Sept · today

(opens in new tab)

Aurobindo Pharma's step-down subsidiary, A1 Biochem Labs (India) Private Limited, has subscribed to 10,000 equity shares of USD 100 each in A1 Biochem USA Inc. This is part of the earlier disclosed ac

BSE · Company Update·12 Sept · 3d ago

(opens in new tab)

Aurobindo Pharma's step-down subsidiary, A1 Biochem Labs (India) Private Limited, has subscribed to 10,000 equity shares of USD 100 each in A1 Biochem USA Inc. This acquisition is part of the earlier

NSE · Acquisition·12 Sept · 3d ago

(opens in new tab)
Neutral / worth noting (4)

Aurobindo Pharma arm Apitoria incorporates Avogent Lifesciences as subsidiary

NewsGoogle News·1 Sept · 2w ago

(opens in new tab)

Aurobindo Pharma Ltd's wholly owned subsidiary, Apitoria Pharma Private Limited, has incorporated a new wholly owned subsidiary named Ávogent Lifesciences Private Limited.

BSE · Company Update·1 Sept · 2w ago

(opens in new tab)

Aurobindo Pharma’s API plant gets three US FDA observations after inspection

NewsCnbc-Tv18·28 Aug · 2w ago

(opens in new tab)

Here's why these four pharma stocks are in focus today

NewsCnbc-Tv18·24 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (3)

USFDA Issues Three Observations To Aurobindo Pharma Arm's Facility In Andhra

NewsNdtv-Profit·28 Aug · 2w ago

(opens in new tab)

Aurobindo Pharma US subsidiary Lannett Company LLC faces 4 observations from the USFDA

NewsLivemint·24 Aug · 3w ago

(opens in new tab)

1 advisor has an active short-term SELL call on this stock

Advisor consensus · adjacent horizon·6 Aug · 1mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Chandan Taparia, Motilal Oswal

Every call and its outcome